Group One Trading’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,771
| Closed | -$423K | – | 2826 |
|
|
2025
Q1 | $423K | Sell |
24,771
-59,937
| -71% | -$1.02M | ﹤0.01% | 627 |
|
|
2024
Q4 | $2.1M | Buy |
+84,708
| New | +$2.1M | ﹤0.01% | 314 |
|
|
2024
Q3 | – | Sell |
-59,007
| Closed | -$1.56M | – | 2370 |
|
|
2024
Q2 | $1.56M | Buy |
59,007
+27,099
| +85% | +$715K | 0.01% | 265 |
|
|
2024
Q1 | $1.03M | Sell |
31,908
-105,599
| -77% | -$3.41M | ﹤0.01% | 326 |
|
|
2023
Q4 | $5.79M | Buy |
+137,507
| New | +$5.79M | 0.02% | 117 |
|
|
2023
Q3 | – | Sell |
-75,991
| Closed | -$1.44M | – | 2602 |
|
|
2023
Q2 | $1.44M | Buy |
75,991
+52,135
| +219% | +$989K | ﹤0.01% | 275 |
|
|
2023
Q1 | $370K | Buy |
+23,856
| New | +$370K | ﹤0.01% | 520 |
|
|
2022
Q4 | – | Sell |
-57,027
| Closed | -$318K | – | 2563 |
|
|
2022
Q3 | $318K | Sell |
57,027
-6,020
| -10% | -$33.6K | ﹤0.01% | 691 |
|
|
2022
Q2 | $246K | Buy |
63,047
+5,937
| +10% | +$23.2K | ﹤0.01% | 807 |
|
|
2022
Q1 | $315K | Sell |
57,110
-27,184
| -32% | -$150K | ﹤0.01% | 894 |
|
|
2021
Q4 | $718K | Buy |
84,294
+4,482
| +6% | +$38.2K | ﹤0.01% | 764 |
|
|
2021
Q3 | $694K | Buy |
79,812
+48,544
| +155% | +$422K | ﹤0.01% | 728 |
|
|
2021
Q2 | $331K | Buy |
31,268
+21,642
| +225% | +$229K | ﹤0.01% | 945 |
|
|
2021
Q1 | $154K | Buy |
+9,626
| New | +$154K | ﹤0.01% | 1099 |
|